These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

63 related items for PubMed ID: 1924657

  • 1. Factors related to haloperidol response and dyskinesias in autistic children.
    Locascio JJ, Malone RP, Small AM, Kafantaris V, Ernst M, Lynch NS, Overall JE, Campbell M.
    Psychopharmacol Bull; 1991; 27(2):119-26. PubMed ID: 1924657
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Neuroleptic-related dyskinesias in autistic children: a prospective, longitudinal study.
    Campbell M, Armenteros JL, Malone RP, Adams PB, Eisenberg ZW, Overall JE.
    J Am Acad Child Adolesc Psychiatry; 1997 Jun; 36(6):835-43. PubMed ID: 9183140
    [Abstract] [Full Text] [Related]

  • 4. Stereotypies and tardive dyskinesia: abnormal movements in autistic children.
    Campbell M, Locascio JJ, Choroco MC, Spencer EK, Malone RP, Kafantaris V, Overall JE.
    Psychopharmacol Bull; 1990 Jun; 26(2):260-6. PubMed ID: 2236468
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Long-term efficacy of haloperidol in autistic children: continuous versus discontinuous drug administration.
    Perry R, Campbell M, Adams P, Lynch N, Spencer EK, Curren EL, Overall JE.
    J Am Acad Child Adolesc Psychiatry; 1989 Jan; 28(1):87-92. PubMed ID: 2914841
    [Abstract] [Full Text] [Related]

  • 7. Haloperidol-related dyskinesias and pre- and perinatal complications in autistic children.
    Armenteros JL, Adams PB, Campbell M, Eisenberg ZW.
    Psychopharmacol Bull; 1995 Jan; 31(2):363-9. PubMed ID: 7491393
    [Abstract] [Full Text] [Related]

  • 8. Differentiation of stereotypies from neuroleptic-related dyskinesias in autistic children.
    Meiselas KD, Spencer EK, Oberfield R, Peselow ED, Angrist B, Campbell M.
    J Clin Psychopharmacol; 1989 Jun; 9(3):207-9. PubMed ID: 2500463
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Plasma beta-endorphin levels, naltrexone, and haloperidol in autistic children.
    Ernst M, Devi L, Silva RR, Gonzalez NM, Small AM, Malone RP, Campbell M.
    Psychopharmacol Bull; 1993 Jun; 29(2):221-7. PubMed ID: 8290669
    [Abstract] [Full Text] [Related]

  • 13. [Psychopharmacology of autism].
    Chabrol H, Bonnet D, Roge B.
    Encephale; 1996 Jun; 22(3):197-203. PubMed ID: 8767048
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Review of psychopharmacological treatments in adolescents and adults with autistic disorders].
    Baghdadli A, Gonnier V, Aussilloux C.
    Encephale; 2002 Jun; 28(3 Pt 1):248-54. PubMed ID: 12091786
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Haloperidol in the treatment of infantile autism: effects on learning and behavioral symptoms.
    Anderson LT, Campbell M, Grega DM, Perry R, Small AM, Green WH.
    Am J Psychiatry; 1984 Oct; 141(10):1195-202. PubMed ID: 6385731
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Tourette-like symptoms associated with neuroleptic therapy in an autistic child.
    Perry R, Nobler MS, Campbell M.
    J Am Acad Child Adolesc Psychiatry; 1989 Jan; 28(1):93-6. PubMed ID: 2914842
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.